Triple negative breast cancer treatment options and limitations: future outlook

O Obidiro, G Battogtokh, EO Akala - Pharmaceutics, 2023 - mdpi.com
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …

Phage display screening in breast cancer: From peptide discovery to clinical applications

AYW Ning, SCY Chun, YW Hsum, WC Loo, ACY Yin… - Life Sciences, 2024 - Elsevier
Breast cancer is known as the most common type of cancer found in women and a leading
cause of cancer death in women, with the global incidence only increasing. Breast cancer in …

Theranostic applications of peptide-based nanoformulations for growth factor defective cancers

A Ghosh, P Maske, V Patel, J Dubey, K Aniket… - International Journal of …, 2024 - Elsevier
Growth factors play a pivotal role in orchestrating cellular growth and division by binding to
specific cell surface receptors. Dysregulation of growth factor production or activity can …

Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway

K Ganesan, C Xu, J Wu, B Du, Q Liu, Y Sui… - Science China Life …, 2024 - Springer
The spreading of cancer cells from the primary tumor site to other parts of the body, known
as metastasis, is the leading cause of cancer recurrence and mortality in patients with triple …

[HTML][HTML] Non-Invasive On–Off Fluorescent Biosensor for Endothelial Cell Detection

Q Jiang, S Shao, N Li, Z Zhang, B Liu - Biosensors, 2024 - mdpi.com
For rapid and convenient detection of living endothelial cells (ECs) specifically without
immunostaining, we developed a biosensor based on turn-on fluorescent protein, named LV …

Glucosyltriazole amphiphile treatment attenuates breast cancer by modulating the AMPK signaling

NK Chouhan, A Eedara, MN Talati… - Drug Development …, 2024 - Wiley Online Library
Breast cancer is the second most frequent cancer among women. Out of various subtypes,
triple‐negative breast cancers (TNBCs) account for 15% of breast cancers and exhibit more …

[PDF][PDF] Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. Pharmaceutics 2023, 15, 1796

O Obidiro, G Battogtokh, EO Akala - 2023 - academia.edu
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …

Cytokine Mimetics with Various Modalities

K Sakai, H Sato, K Matsumoto - Israel Journal of Chemistry, 2024 - Wiley Online Library
Cytokines play a central role in regulating cell communication and signal transduction, since
they influence processes such as immunity, hematopoiesis, inflammatory disease, cancer …